Older age is by far the strongest risk factor for severe COVID-19, followed by deprivation, non-white ethnicity, male sex, and chronic medical conditions.1 Such information can guide protection and vaccination strategies, and can provide leads for causal inference and development of novel treatments.
When Eli Lilly started its US direct-to-consumer service earlier this year, it did so with the stated aim of offering “patients an innovative end-to-end experience…
Pharmacotherapy approved to support people living with obesity has received much attention from the scientific and clinical communities, and general public. Clinical trials have reported…
Virtually every country in the world has shown a dramatic increase in the prevalence of overweight and obesity since the 1980s. Rapidly changing dietary patterns,…
Type 1 diabetes is characterised by substantial disease heterogeneity which influences rates of progression during presymptomatic stages, age at clinical onset, and residual β-cell function…
Treatment-related BMD changes are strongly associated with fracture reductions across randomised trials of osteoporosis therapies with differing mechanisms of action. These analyses support BMD as…
Insulin products should be refrigerated at 2–8°C before first use and can be stored at ambient temperatures (ie, 25–30°C) after opening for 4–6 weeks, as…
Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are…
The study by Victoria Miller and colleagues1 in The Lancet Diabetes & Endocrinology adds to and extends the growing body of evidence of the importance…
Diets with a high glycaemic index and a high glycaemic load were associated with a higher risk of incident type 2 diabetes in a multinational…
Diabetes is a common chronic disease that affects up to 10% of adults worldwide.1 People with diabetes are at high risk for a wide variety…
